Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

País/Região como assunto
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Acta Trop ; 193: 23-30, 2019 May.
Artigo em Inglês | MEDLINE | ID: mdl-30771283

RESUMO

BACKGROUND: Chagas disease is an important health problem in Latin America. Relatives of T. cruzi seropositive donors could also test positive in serological assays. Therefore, the study of Chagas diseases in family clusters has become important to accurately evaluate the problem that this infectious disease represents. OBJECTIVE: to investigate family cluster from blood donors, their serological, clinical and epidemiological status. METHODS: 53 family clusters consisting of index case and a variable number of relatives were studied. All the participants had ELISA and Western blot assays, as well as, clinical tests including an electrocardiogram and chest x ray. RESULTS: We found that 24.52% of the family clusters had at least one T. cruzi seropositive family member, in addition to the blood donor. Importantly, 20.75% of the index cases and 5.0% of the relatives presented pathological manifestations associated to Chagas disease. Several epidemiological conditions are associated to being T. cruzi seropositive. CONCLUSION: blood donor's family clusters have several seropositive to T. cruzi members. Mother-child pairs were also seropositive, suggesting vertical transmition. Pathological symptom associated to Chagas Diseases were present in index cases and family member. These results highlight the importance of studying family clusters to clarify the true magnitude of Chagas disease in Mexico.


Assuntos
Anticorpos Antiprotozoários/sangue , Doença de Chagas/epidemiologia , Família , Trypanosoma cruzi/imunologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Doadores de Sangue/estatística & dados numéricos , Doença de Chagas/sangue , Doença de Chagas/diagnóstico , Criança , Pré-Escolar , Análise por Conglomerados , Feminino , Humanos , Masculino , México/epidemiologia , Pessoa de Meia-Idade , Adulto Jovem
2.
Cir Cir ; 76(4): 305-9, 2008.
Artigo em Espanhol | MEDLINE | ID: mdl-18778540

RESUMO

BACKGROUND: Frequency of adrenal insufficiency in patients with tuberculosis varies from 0 to 58%; however, all published series excluded severely ill patients. Our objective was to investigate adrenal insufficiency with the low-dose cosyntropin test in patients with severe active tuberculosis. METHOD: From two large university affiliated hospitals, 18 patients with tuberculosis and criteria of sepsis or severe sepsis according to SCCM/ACCP criteria, defined by the present authors as severe active tuberculosis, participated in the study. A low-dose ACTH test with 10 mg of ACTH was performed. After ACTH test, all patients received a stress dose of hydrocortisone (240 mg/day) during their entire hospitalization along with four antituberculous drugs. Abnormal response was considered when elevation of serum cortisol was <7 microg/dl with respect to basal level, 60 min after ACTH administration. RESULTS: Adrenal insufficiency was found in seven patients (39%); no clinical or laboratory data were associated with the presence of abnormal adrenal response. Except in one patient with HIV infection, all the signs and symptoms improved after antituberculous and hydrocortisone treatment. The increment in serum cortisol value post-ACTH test was lower in patients with hypoalbuminemia. CONCLUSIONS: Adrenal insufficiency is frequent in severe active tuberculosis. The efficacy and security of supplemental steroid treatment in severe active tuberculosis should be established by a randomized clinical trial.


Assuntos
Insuficiência Adrenal/diagnóstico , Cosintropina , Hidrocortisona/sangue , Tuberculose Pulmonar/complicações , Insuficiência Adrenal/tratamento farmacológico , Insuficiência Adrenal/etiologia , Adulto , Antituberculosos/uso terapêutico , Cosintropina/administração & dosagem , Quimioterapia Combinada , Etambutol/administração & dosagem , Feminino , Infecções por HIV/complicações , Humanos , Hidrocortisona/metabolismo , Hidrocortisona/uso terapêutico , Isoniazida/uso terapêutico , Masculino , Pessoa de Meia-Idade , Pirazinamida/administração & dosagem , Rifampina/uso terapêutico , Sepse/tratamento farmacológico , Sepse/etiologia , Sepse/fisiopatologia , Tuberculose Miliar/complicações , Tuberculose Miliar/tratamento farmacológico , Tuberculose Miliar/fisiopatologia , Tuberculose Pulmonar/tratamento farmacológico , Tuberculose Pulmonar/fisiopatologia
3.
Cir. & cir ; 76(4): 305-309, jul.-ago. 2008. tab, graf
Artigo em Espanhol | LILACS | ID: lil-568082

RESUMO

BACKGROUND: Frequency of adrenal insufficiency in patients with tuberculosis varies from 0 to 58%; however, all published series excluded severely ill patients. Our objective was to investigate adrenal insufficiency with the low-dose cosyntropin test in patients with severe active tuberculosis. METHOD: From two large university affiliated hospitals, 18 patients with tuberculosis and criteria of sepsis or severe sepsis according to SCCM/ACCP criteria, defined by the present authors as severe active tuberculosis, participated in the study. A low-dose ACTH test with 10 mg of ACTH was performed. After ACTH test, all patients received a stress dose of hydrocortisone (240 mg/day) during their entire hospitalization along with four antituberculous drugs. Abnormal response was considered when elevation of serum cortisol was <7 microg/dl with respect to basal level, 60 min after ACTH administration. RESULTS: Adrenal insufficiency was found in seven patients (39%); no clinical or laboratory data were associated with the presence of abnormal adrenal response. Except in one patient with HIV infection, all the signs and symptoms improved after antituberculous and hydrocortisone treatment. The increment in serum cortisol value post-ACTH test was lower in patients with hypoalbuminemia. CONCLUSIONS: Adrenal insufficiency is frequent in severe active tuberculosis. The efficacy and security of supplemental steroid treatment in severe active tuberculosis should be established by a randomized clinical trial.


Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Cosintropina , Hidrocortisona/sangue , Insuficiência Adrenal/diagnóstico , Tuberculose Pulmonar/complicações , Antituberculosos/uso terapêutico , Cosintropina/administração & dosagem , Quimioterapia Combinada , Etambutol/administração & dosagem , Hidrocortisona , Hidrocortisona/uso terapêutico , Infecções por HIV/complicações , Insuficiência Adrenal/tratamento farmacológico , Insuficiência Adrenal/etiologia , Isoniazida/uso terapêutico , Pirazinamida/administração & dosagem , Rifampina/uso terapêutico , Sepse/tratamento farmacológico , Sepse/etiologia , Sepse/fisiopatologia , Tuberculose Miliar/complicações , Tuberculose Miliar/tratamento farmacológico , Tuberculose Miliar/fisiopatologia , Tuberculose Pulmonar/tratamento farmacológico , Tuberculose Pulmonar/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA